Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Updates in Management of Hypercortisolism in Type 2 Diabetes, with Ralph DeFronzo, MD

    Updates in Management of Hypercortisolism in Type 2 Diabetes, with Ralph DeFronzo, MD

    FromDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

    Start listeningView podcast show

    Updates in Management of Hypercortisolism in Type 2 Diabetes, with Ralph DeFronzo, MD

    FromDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

    ratings:
    Length:
    32 minutes
    Released:
    Jan 9, 2024
    Format:
    Podcast episode

    Description

    In this episode, hosts sit down with Ralph DeFronzo, MD, for a discussion on how advances in management have transformed the diagnosis and management of hypercortisolism among people with type 2 diabetes.

    Episode Highlights

    00:39 DeFronzo Introduction
    01:54 Presentation of Hypercortisolism
    05:50 Ominous Octet and Hypercortisolism
    09:47 Prevalence of Hypercortisolism in T2D
    13:57 Impact of Untreated Hypercortisolism
    17:05 Screening for Hypercortisolism
    21:25 CATALYST Trial
    31:30 Outro
    Released:
    Jan 9, 2024
    Format:
    Podcast episode

    Titles in the series (94)

    Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives is a podcast hosted by Drs. Diana Isaacs and Natalie Bellini aimed at providing a regular roundup of the latest clinically applicable insights across diabetes and metabolic diseases, with a focus on leveraging technology to improve care. A video version of each episode is available at http://HCPLive.com/Clinical/Endocrinology. Please direct podcast-related inquiries to PCampbell@MJHLifesciences.com. Editor's note: Episodes predating January 2023 were hosted by Endocrinology Network. Episodes predating March 2022 were titled The Endocrine Outlook.